{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:51:34Z","timestamp":1791942694684,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xi\u2019an Municipal Health Commission Research Project","award":["2025yb26"],"award-info":[{"award-number":["2025yb26"]}]},{"name":"Xi\u2019an Basic Ability Enhancement Program for Scientific and Technological Innovation","award":["2025YXYJ0072"],"award-info":[{"award-number":["2025YXYJ0072"]}]},{"name":"Xi\u2019an Basic Ability Enhancement Program for Scientific and Technological Innovation","award":["24YXYJ0076"],"award-info":[{"award-number":["24YXYJ0076"]}]},{"name":"Shaanxi Provincial Key Research and Development Program","award":["2025SF-YBXM-052"],"award-info":[{"award-number":["2025SF-YBXM-052"]}]},{"name":"Shaanxi Provincial Traditional Chinese Medicine Scientific Innovation and Capacity Improvement Plan","award":["TZKN-CXPT-04"],"award-info":[{"award-number":["TZKN-CXPT-04"]}]},{"name":"Research Project of Shaanxi Provincial Health Commission","award":["2021B001"],"award-info":[{"award-number":["2021B001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-025-00589-6","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:45:20Z","timestamp":1762962320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TNF-\u03b1 inhibitor etanercept improves cerebrovascular function in elderly RA patients: findings from a randomized controlled trial"],"prefix":"10.1186","volume":"9","author":[{"given":"Qiao-qiao","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-ku","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"6","key":"589_CR1","doi-asserted-by":"publisher","first-page":"102528","DOI":"10.1016\/j.autrev.2020.102528","volume":"19","author":"L Serhal","year":"2020","unstructured":"Serhal L, Lwin MN, Holroyd C, Edwards CJ. Rheumatoid arthritis in the elderly: characteristics and treatment considerations. Autoimmun Rev. 2020;19(6):102528.","journal-title":"AUTOIMMUN REV"},{"key":"589_CR2","doi-asserted-by":"publisher","first-page":"152570","DOI":"10.1016\/j.semarthrit.2024.152570","volume":"69","author":"E Lovering","year":"2024","unstructured":"Lovering E, Kodishala C, George RJ, Kumar R, Crowson CS, Lennon RJ, Davis JR, Myasoedova E. The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis. Semin Arthritis Rheu. 2024;69:152570.","journal-title":"SEMIN ARTHRITIS RHEU"},{"issue":"2","key":"589_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00296-024-05781-4","volume":"45","author":"M Ausserwinkler","year":"2025","unstructured":"Ausserwinkler M, Gensluckner S, Frey V, Gostner I, Paulweber B, Trinka E, Langthaler P, Datz C, Iglseder B, Thiel J, et al. Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the paracelsus 10,000 study. Rheumatol Int. 2025;45(2):33.","journal-title":"RHEUMATOL INT"},{"issue":"13","key":"589_CR4","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA-J Am Med Assoc. 2018;320(13):1360\u201372.","journal-title":"JAMA-J AM MED ASSOC"},{"issue":"24","key":"589_CR5","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2174\/1381612828666220527141532","volume":"28","author":"B Dubiel-Braszczok","year":"2022","unstructured":"Dubiel-Braszczok B, Nowak K, Owczarek A, Engelmann M, Gumkowska-Sroka O, Kotyla PJ. Differential impact of biologic therapy on heart function biomarkers in rheumatoid arthritis patients: observational study on Etanercept, Adalimumab, and Tocilizumab. Curr Pharm Des. 2022;28(24):2029\u201337.","journal-title":"CURR PHARM Des"},{"issue":"4","key":"589_CR6","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev. 2021;20(4):102776.","journal-title":"AUTOIMMUN REV"},{"key":"589_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neuroimage.2018.07.007","volume":"181","author":"L McKetton","year":"2018","unstructured":"McKetton L, Sobczyk O, Duffin J, Poublanc J, Sam K, Crawley AP, Venkatraghavan L, Fisher JA, Mikulis DJ. The aging brain and cerebrovascular reactivity. Neuroimage. 2018;181:132\u201341.","journal-title":"NeuroImage"},{"key":"589_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuroimage.2018.03.033","volume":"174","author":"SL Peng","year":"2018","unstructured":"Peng SL, Chen X, Li Y, Rodrigue KM, Park DC, Lu H. Age-related changes in cerebrovascular reactivity and their relationship to cognition: a four-year longitudinal study. Neuroimage. 2018;174:257\u201362.","journal-title":"NeuroImage"},{"issue":"4","key":"589_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/RUQ.0000000000000312","volume":"33","author":"Q Chen","year":"2017","unstructured":"Chen Q, Li S, Lv G, Zhao Y. Application of transcranial color doppler ultrasonography for assessing middle cerebral arteries in rheumatoid arthritis. Ultrasound Q. 2017;33(4):281\u20133.","journal-title":"ULTRASOUND Q"},{"issue":"9","key":"589_CR10","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/art.27580","volume":"62","author":"T Neogi","year":"2010","unstructured":"Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, Bingham CR, Birnbaum NS, Burmester GR, Bykerk VP, et al. The 2010 American college of Rheumatology\/European league against rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum. 2010;62(9):2582\u201391.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"589_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jon.12508","volume":"28","author":"M Alwatban","year":"2018","unstructured":"Alwatban M, Truemper EJ, Al-Rethaia A, Murman DL, Bashford GR. The Breath-Hold acceleration index: a new method to evaluate cerebrovascular reactivity using transcranial doppler. J Neuroimaging. 2018;28(4):429\u201335.","journal-title":"J NEUROIMAGING"},{"issue":"10055","key":"589_CR12","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023\u201338.","journal-title":"Lancet"},{"key":"589_CR13","doi-asserted-by":"publisher","first-page":"745224","DOI":"10.3389\/fgene.2021.745224","volume":"12","author":"S Qiu","year":"2021","unstructured":"Qiu S, Li M, Jin S, Lu H, Hu Y. Rheumatoid arthritis and Cardio-Cerebrovascular disease: a mendelian randomization study. Front Genet. 2021;12:745224.","journal-title":"FRONT GENET"},{"issue":"SI3","key":"589_CR14","doi-asserted-by":"publisher","first-page":"SI296","DOI":"10.1093\/rheumatology\/kead396","volume":"62","author":"RA Larsen","year":"2023","unstructured":"Larsen RA, Constantopoulos E, Kodishala C, Lovering E, Kumar R, Hulshizer CA, Lennon RJ, Crowson CS, Nguyen AT, Myasoedova E. Neuropathologic evaluation of cerebrovascular disease in patients with rheumatoid arthritis. Rheumatology. 2023;62(SI3):SI296\u2013303.","journal-title":"Rheumatology"},{"issue":"5","key":"589_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/joim.12406","volume":"278","author":"GK Hansson","year":"2015","unstructured":"Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278(5):483\u201393.","journal-title":"J INTERN MED"},{"key":"589_CR16","doi-asserted-by":"crossref","unstructured":"Maiuolo J, Muscoli C, Gliozzi M, Musolino V, Carresi C, Paone S, Ilari S, Mollace R, Palma E, Mollace V. Endothelial dysfunction and extra-articular neurological manifestations in rheumatoid arthritis. Biomolecules. 2021;11(1).","DOI":"10.3390\/biom11010081"},{"issue":"11","key":"589_CR17","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1161\/ATVBAHA.123.319695","volume":"43","author":"N Colas-Algora","year":"2023","unstructured":"Colas-Algora N, Munoz-Pinillos P, Cacho-Navas C, Avendano-Ortiz J, de Rivas G, Barroso S, Lopez-Collazo E, Millan J. Simultaneous targeting of IL-1-Signaling and IL-6-Trans-Signaling preserves human pulmonary endothelial barrier function during a cytokine storm-brief report. Arterioscl Throm Vas. 2023;43(11):2213\u201322.","journal-title":"ARTERIOSCL THROM VAS"},{"issue":"9","key":"589_CR18","doi-asserted-by":"publisher","first-page":"166170","DOI":"10.1016\/j.bbadis.2021.166170","volume":"1867","author":"MF Troncoso","year":"2021","unstructured":"Troncoso MF, Ortiz-Quintero J, Garrido-Moreno V, Sanhueza-Olivares F, Guerrero-Moncayo A, Chiong M, Castro PF, Garcia L, Gabrielli L, Corbalan R, et al. VCAM-1 as a predictor biomarker in cardiovascular disease. BBA-Mol Basis Dis. 2021;1867(9):166170.","journal-title":"BBA-MOL BASIS DIS"},{"issue":"1","key":"589_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.55563\/clinexprheumatol\/ubov8b","volume":"39","author":"C He","year":"2021","unstructured":"He C, Chen J, Luo X, Yan B. Evaluation of biomarkers related to endothelial dysfunction: proof of vasculopathy in anti-melanoma differentiation-associated gene 5 dermatomyositis. Clin Exp Rheumatol. 2021;39(1):151\u20137.","journal-title":"CLIN EXP RHEUMATOL"},{"issue":"10","key":"589_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1080\/14712598.2024.2404521","volume":"24","author":"N Nooh","year":"2024","unstructured":"Nooh N, Lwin MN, Edwards C. Considerations for the use of biological therapies in elderly patients with rheumatoid arthritis. Expert Opin Biol Th. 2024;24(10):1109\u201317.","journal-title":"EXPERT OPIN BIOL TH"},{"issue":"2","key":"589_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.55563\/clinexprheumatol\/ftfgmf","volume":"39","author":"JH Koh","year":"2021","unstructured":"Koh JH, Lee SK, Kim J, Kim HA, Shin K, Min JK. Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO registry. Clin Exp Rheumatol. 2021;39(2):269\u201378.","journal-title":"CLIN EXP RHEUMATOL"},{"issue":"4","key":"589_CR22","doi-asserted-by":"publisher","first-page":"e70232","DOI":"10.1111\/1756-185X.70232","volume":"28","author":"K Sonomoto","year":"2025","unstructured":"Sonomoto K, Tanaka Y. Targeted therapies for rheumatoid arthritis in Super-Elderly society: insights from FIRST Registry, Japan. Int J Rheum Dis. 2025;28(4):e70232.","journal-title":"INT J RHEUM DIS"},{"issue":"2","key":"589_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/mr\/roab003","volume":"32","author":"K Ebina","year":"2022","unstructured":"Ebina K. Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis. Mod Rheumatol. 2022;32(2):256\u201362.","journal-title":"MOD RHEUMATOL"},{"issue":"4","key":"589_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, et al. Cardiovascular and cancer risk with Tofacitinib in rheumatoid arthritis. New Engl J Med. 2022;386(4):316\u201326.","journal-title":"NEW ENGL J MED"},{"issue":"1","key":"589_CR25","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/s41598-019-38670-z","volume":"9","author":"NR Bonetti","year":"2019","unstructured":"Bonetti NR, Diaz-Canestro C, Liberale L, Crucet M, Akhmedov A, Merlini M, Reiner MF, Gobbato S, Stivala S, Kollias G, et al. Tumour necrosis Factor-alpha Inhibition improves stroke outcome in a mouse model of rheumatoid arthritis. Sci REP-UK. 2019;9(1):2173.","journal-title":"SCI REP-UK"},{"key":"589_CR26","doi-asserted-by":"publisher","first-page":"727832","DOI":"10.3389\/fnagi.2021.727832","volume":"13","author":"J Staszewski","year":"2021","unstructured":"Staszewski J, Debiec A, Skrobowska E, Stepien A. Cerebral vasoreactivity changes over time in patients with different clinical manifestations of cerebral small vessel disease. Front Aging Neurosci. 2021;13:727832.","journal-title":"FRONT AGING NEUROSCI"},{"issue":"1","key":"589_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13075-025-03608-6","volume":"27","author":"JD Veale","year":"2025","unstructured":"Veale JD, Gorman A, Veale DJ, Fearon U, Orr C, Marzaioli V. Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures. Arthritis Res Ther. 2025;27(1):147.","journal-title":"ARTHRITIS RES THER"},{"key":"589_CR28","doi-asserted-by":"crossref","unstructured":"Shilkina NP, Spirin NN, Yunonin IE, Vinogradov AA. [Cerebral perfusion, arterial hypertension and endothelial dysfunction in rheumatoid arthritis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(3 Vyp 2):68\u201375.","DOI":"10.17116\/jnevro201911903268"},{"key":"589_CR29","doi-asserted-by":"crossref","unstructured":"Szeremeta A, Jura-Poltorak A, Zon-Giebel A, Olczyk K, Komosinska-Vassev K. TNF-alpha inhibitors in combination with MTX reduce circulating levels of heparan sulfate\/heparin and endothelial dysfunction biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in women with rheumatoid arthritis. J Clin Med. 2022;11(14).","DOI":"10.3390\/jcm11144213"},{"issue":"9","key":"589_CR30","doi-asserted-by":"publisher","first-page":"e0203607","DOI":"10.1371\/journal.pone.0203607","volume":"13","author":"A Leblond","year":"2018","unstructured":"Leblond A, Pezet S, Trouvin AP, Elhai M, Gonzalez V, Allanore Y, Avouac J. Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis. PLoS One. 2018;13(9):e0203607.","journal-title":"PLoS ONE"},{"key":"589_CR31","doi-asserted-by":"crossref","unstructured":"Banecki K, Dora KA. Endothelin-1 in health and disease. Int J Mol Sci. 2023;24(14).","DOI":"10.3390\/ijms241411295"},{"issue":"5","key":"589_CR32","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s10787-022-01051-6","volume":"30","author":"A Sehgal","year":"2022","unstructured":"Sehgal A, Behl T, Singh S, Sharma N, Albratty M, Alhazmi HA, Meraya AM, Aleya L, Sharma A, Bungau S. Exploring the pivotal role of endothelin in rheumatoid arthritis. Inflammopharmacology. 2022;30(5):1555\u201367.","journal-title":"Inflammopharmacology"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-025-00589-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:45:33Z","timestamp":1762962333000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-025-00589-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s41927-025-00589-6","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was registered in the Chinese Clinical Trial Registry (Registration No.: ChiCTR2300077337; Date of Registration: 01\/11\/2023). Prior to participation, written informed consent was obtained from all individuals involved in the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}